Addressing Social Determinants of Health in the Care of Patients With Heart Failure: A Scientific Statement From the American Heart Association.
Delivery of Health Care
Educational Status
Environmental Exposure
Ethnicity
Food Insecurity
Gender Identity
Health Literacy
Health Services Accessibility
Health Status Disparities
Heart Failure
/ economics
Humans
Insurance Coverage
Minority Groups
Models, Theoretical
Pharmaceutical Preparations
/ supply & distribution
Poverty
Racial Groups
Social Class
Social Determinants of Health
Social Support
Unemployment
Vulnerable Populations
AHA Scientific Statements
health personnel
heart failure
social determinants of health
Journal
Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763
Informations de publication
Date de publication:
02 06 2020
02 06 2020
Historique:
pubmed:
1
5
2020
medline:
8
6
2021
entrez:
1
5
2020
Statut:
ppublish
Résumé
Heart failure is a clinical syndrome that affects >6.5 million Americans, with an estimated 550 000 new cases diagnosed each year. The complexity of heart failure management is compounded by the number of patients who experience adverse downstream effects of the social determinants of health (SDOH). These patients are less able to access care and more likely to experience poor heart failure outcomes over time. Many patients face additional challenges associated with the cost of complex, chronic illness management and must make difficult decisions about their own health, particularly when the costs of medications and healthcare appointments are at odds with basic food and housing needs. This scientific statement summarizes the SDOH and the current state of knowledge important to understanding their impact on patients with heart failure. Specifically, this document includes a definition of SDOH, provider competencies, and SDOH assessment tools and addresses the following questions: (1) What models or frameworks guide healthcare providers to address SDOH? (2) What are the SDOH affecting the delivery of care and the interventions addressing them that affect the care and outcomes of patients with heart failure? (3) What are the opportunities for healthcare providers to address the SDOH affecting the care of patients with heart failure? We also include a case study (Data Supplement) that highlights an interprofessional team effort to address and mitigate the effects of SDOH in an underserved patient with heart failure.
Identifiants
pubmed: 32349541
doi: 10.1161/CIR.0000000000000767
doi:
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Guideline
Journal Article
Langues
eng
Sous-ensembles de citation
IM